Gossamer Bio, Inc.
GOSS
$1.45
$0.1511.54%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -8.48% | -13.10% | -5.58% | -29.43% | -19.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.18% | -5.47% | -12.45% | -28.18% | -27.70% |
| Operating Income | 16.23% | 212.54% | 12.45% | 28.18% | 27.70% |
| Income Before Tax | 20.18% | 226.29% | 14.72% | 13.66% | 32.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.01% | 215.85% | 14.72% | 13.66% | 32.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.01% | 215.85% | 14.72% | 13.66% | 32.60% |
| EBIT | 16.23% | 212.54% | 12.45% | 28.18% | 27.70% |
| EBITDA | 15.96% | 214.22% | 12.14% | 28.11% | 27.80% |
| EPS Basic | 34.38% | 148.88% | 64.16% | 63.89% | 68.14% |
| Normalized Basic EPS | 31.94% | 153.31% | 62.71% | 65.16% | 68.14% |
| EPS Diluted | 34.38% | 148.20% | 63.46% | 63.89% | 68.14% |
| Normalized Diluted EPS | 31.94% | 150.54% | 62.71% | 65.16% | 68.14% |
| Average Basic Shares Outstanding | 17.35% | 137.01% | 137.94% | 139.08% | 111.54% |
| Average Diluted Shares Outstanding | 17.35% | 149.92% | 137.94% | 139.08% | 111.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
